Y-320, a novel immune-modulator, sensitizes multidrug-resistant tumors to chemotherapy

Y-320, a novel immune-modulator, inhibits IL-17 production by CD4(+) T cells stimulated with IL-15. Its use in autoimmune diseases such as rheumatoid arthritis has been documented. However, no studies have be conducted to evaluate its application in cancer treatment either as mono or combined therap...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Am J Transl Res
Autori principali: Hong, Jiawei, Jing, Shilei, Zhang, Yanpeng, Chen, Ronggao, Owusu-Ansah, Kwabena Gyabaah, Chen, Bingjie, Xie, Haiyang, Zhou, Lin, Zheng, Shusen, Jiang, Donghai
Natura: Artigo
Lingua:Inglês
Pubblicazione: e-Century Publishing Corporation 2020
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7061851/
https://ncbi.nlm.nih.gov/pubmed/32194903
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi